Targeting SARM1 and Axon Degeneration as a Design-Modifying Strategy for the Treatment of CMT2A Play video: Targeting SARM1 and Axon Degeneration as a Design-Modifying Strategy for the Treatment of CMT2ATechnicalThursday, Sept 25 · Researcher DayBradlee Heckmann · Asha TherapeuticsBack to all sessions
